Ultra high-quality plastic syringe systems provide a compelling alternative to glass syringe systems.  Through simplified usage, support for new classes of biopharmaceutical products, reduced waste, break-resistance, dosage precision and minimized extractables, plastic prefillable syringes present attractive benefits that are gaining increased attention from manufacturers seeking new answers to toady’s and tomorrow’s drug-delivery and administration challenges.

Additionally, rapid growth of injection devices has become increasingly prevalent in pharmaceutical drug delivery.  There is an emerging need to minimize or eliminate protein aggregation due to silicone oil interaction, reduce contamination due to extractables and minimize drug loss due to adsorption.  Choosing the right injection system can mitigate these protein aggregation and instability issues. 

West Senior Director Scott G. Young, PH.D., will discuss the key attributes of a silicone-free prefillable syringe system including syringe functional performance attributes, which are ideal for these biopharmaceutical drug delivery applications, at the ISPE Tampa Conference, “Applying Solutions to Emerging Industry Challenges.”  The conference will be held February 22-25 at the Grand Hyatt Tampa Bay in Tampa, Florida.

For more information about the conference, or to register to attend, visit www.ISPE.org/2010TampaConference.

Scott G. Young, Ph.D.
Senior Director
Scott.Young@westpharma.com 
610.594.3135

Dr. Young has more than 20 years of extensive expertise in the area of medical device design and materials development. His previous industrial experience includes employment at American Cyanamid, Shell Chemical Company and WL Gore.